Q&A on Reducing COVID-19 Risk for Elderly, Immunocompromised

While the risks associated with COVID-19 generally have decreased over time due to prior exposure to the vaccines and the virus, some people remain at elevated risk, such as the elderly and immunocompromised. The updated COVID-19 vaccines and, in some cases, a new monoclonal antibody can provide increased protection for this group.“At this point, many people have had multiple vaccines and we are seeing a lot less severe and life-threatening illness, especially in people who have had recent vaccination,” Dr. Camille Kotton, clinical director of Transplant and Immunocompromised Host Infectious Diseases at Massachusetts General Hospital, told us. “Nonetheless, we are still seeing significant severe disease, hospitalization, even life-threatening disease, especially in people over the age of 65 or who are immunocompromised.”We spoke with Kotton, who is also a member of the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices, or ACIP, about the current state of affairs for people at elevated risk of severe disease from COVID-19 and the tools they can use to protect themselves.For some people who are immunocompromised, a newly authorized monoclonal antibody, Pemgarda, or pemivibart, may provide an additional layer of protection, Kotton said. These antibodies may substitute for a person’s own antibodies...